Critical

Mucormycosis

Mucor · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Mucormycosis is an aggressive angioinvasive mould infection (rhino-orbital-cerebral, pulmonary, cutaneous) affecting diabetics (ketoacidosis), haematology patients and the immunosuppressed. Survival depends on rapid surgical debridement, high-dose amphotericin and reversing predisposing factors.

Red flags

  • Black necrotic eschar on palate/nasal mucosa
  • Orbital/periorbital swelling, ophthalmoplegia, vision loss
  • Altered consciousness (cerebral extension)
  • Rapidly progressive necrosis
  • Haemoptysis in pulmonary disease

Assessment

Differential diagnosis

  • Invasive aspergillosis
  • Bacterial orbital cellulitis/sinusitis
  • Cavernous sinus thrombosis
  • Malignancy
  • Other invasive mould

Investigations

  • Urgent CT/MRI of sinuses, orbit, brain or chest
  • Tissue biopsy with histology (broad non-septate hyphae) and culture
  • Blood glucose and ketones (diabetic ketoacidosis)
  • Assess immunosuppression and iron-overload states
  • Nasal endoscopy for black necrotic eschar
  • Renal function before/during amphotericin

Management

  • Suspect urgently in diabetic ketoacidosis or neutropenia with facial/sinus necrosis or refractory pneumonia
  • Obtain emergent imaging and tissue biopsy for histology and culture
  • Correct hyperglycaemia/ketoacidosis and reduce immunosuppression immediately
  • Start high-dose liposomal amphotericin B without delay
  • Arrange emergency surgical debridement of all necrotic tissue (often repeated)
  • Stop deferoxamine and address iron overload if relevant
  • Involve multidisciplinary team (ENT/ophthalmology/neurosurgery/ID)
  • Monitor renal function and electrolytes on amphotericin
  • Step down/add isavuconazole or posaconazole as appropriate
  • Continue prolonged therapy guided by response
  • Reassess with repeat imaging and surgical review
  • Treat underlying condition to prevent relapse

Drugs & doses

Liposomal amphotericin B 5-10 mg/kg IV daily (first line, high dose)
Isavuconazole 200 mg (loading every 8 h x6 doses) then 200 mg daily (step-down/salvage)
Posaconazole (delayed-release) 300 mg daily after loading (salvage/oral step-down)
Insulin/fluids to correct diabetic ketoacidosis as adjunct

Disposition

Admit (critical); emergency surgery; multidisciplinary (ENT/neurosurgery/ID); ICU as needed.

Complications & pitfalls

  • Cerebral invasion and stroke
  • Vision loss and orbital destruction
  • Dissemination
  • Massive haemorrhage (pulmonary)
  • High mortality despite treatment

Exam pearls

  • Surgery plus high-dose amphotericin and metabolic correction is the triad for survival
  • Voriconazole does not cover mucorales (and prior voriconazole is a risk factor)
  • Reverse ketoacidosis and iron overload urgently
  • Non-septate ribbon-like hyphae on histology distinguish from aspergillus
  • Time to treatment strongly predicts survival - do not wait for culture

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.